Literature DB >> 22236474

Lymphocyte signaling: regulation of FoxO transcription factors by microRNAs.

Claudia Haftmann1, Anna-Barbara Stittrich, Evridiki Sgouroudis, Mareen Matz, Hyun-Dong Chang, Andreas Radbruch, Mir-Farzin Mashreghi.   

Abstract

The Forkhead box O (FoxO) family of transcription factors is important for the maintenance of immunological homeostasis and tolerance by controlling the development and function of B and T lymphocytes. Because dysregulation in FoxO activity can result in chronic inflammation and autoimmunity, the transcriptional activity of FoxO proteins is tightly controlled and generally dependent on complex posttranslational modifications that lead either to their nuclear entry and subsequent activation or, alternatively, to their nuclear export. The phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB/Akt) axis represents the major pathway phosphorylating and thereby inactivating FoxO proteins. However, recent results have revealed an additional posttranscriptional mechanism of FoxO inactivation by microRNAs. The discovery of this molecular pathway may provide a new therapeutic avenue for the modulation of FoxO activity in immune-mediated diseases using either microRNA targeting antagomirs or synthetic microRNA mimics, a topic that is addressed in this review.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236474     DOI: 10.1111/j.1749-6632.2011.06264.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

Review 1.  FOXOs in cancer immunity: Knowns and unknowns.

Authors:  Youcai Deng; Fangjie Wang; Tiffany Hughes; Jianhua Yu
Journal:  Semin Cancer Biol       Date:  2018-01-05       Impact factor: 15.707

2.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

Review 3.  Posttranscriptional regulation of FOXO expression: microRNAs and beyond.

Authors:  P Urbánek; L-O Klotz
Journal:  Br J Pharmacol       Date:  2016-05-02       Impact factor: 8.739

Review 4.  Involvement of MicroRNA in T-Cell Differentiation and Malignancy.

Authors:  Najmaldin Saki; Saeid Abroun; Masoud Soleimani; Saeideh Hajizamani; Mohammad Shahjahani; Richard E Kast; Yousef Mortazavi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-01-01

5.  MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.

Authors:  Heounjeong Go; Ji-Young Jang; Pil-Jong Kim; Young-Goo Kim; Soo Jeong Nam; Jin Ho Paik; Tae Min Kim; Dae Seog Heo; Chul-Woo Kim; Yoon Kyung Jeon
Journal:  Oncotarget       Date:  2015-06-20

6.  Increased miR-223 expression in foetal organs is a signature of acute chorioamnionitis with systemic consequences.

Authors:  JoonHo Lee; Chong Jai Kim; Jung-Sun Kim; Deug-Chan Lee; Sejin Ahn; Bo Hyun Yoon
Journal:  J Cell Mol Med       Date:  2017-10-30       Impact factor: 5.310

7.  MicroRNA-31 Reduces the Motility of Proinflammatory T Helper 1 Lymphocytes.

Authors:  Markus Bardua; Claudia Haftmann; Pawel Durek; Kerstin Westendorf; Antje Buttgereit; Cam Loan Tran; Mairi McGrath; Melanie Weber; Katrin Lehmann; Richard Kwasi Addo; Gitta Anne Heinz; Anna-Barbara Stittrich; Patrick Maschmeyer; Helena Radbruch; Michael Lohoff; Hyun-Dong Chang; Andreas Radbruch; Mir-Farzin Mashreghi
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

8.  miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim.

Authors:  Claudia Haftmann; Anna-Barbara Stittrich; Jakob Zimmermann; Zhuo Fang; Kristyna Hradilkova; Markus Bardua; Kerstin Westendorf; Gitta A Heinz; René Riedel; Julia Siede; Katrin Lehmann; Esther E Weinberger; David Zimmel; Uta Lauer; Thomas Häupl; Joachim Sieper; Marina Backhaus; Christian Neumann; Ute Hoffmann; Martina Porstner; Wei Chen; Joachim R Grün; Ria Baumgrass; Mareen Matz; Max Löhning; Alexander Scheffold; Jürgen Wittmann; Hyun-Dong Chang; Nikolaus Rajewsky; Hans-Martin Jäck; Andreas Radbruch; Mir-Farzin Mashreghi
Journal:  Eur J Immunol       Date:  2015-01-22       Impact factor: 5.532

9.  Ursodeoxycholic acid influences the expression of p27kip1 but not FoxO1 in patients with non-cirrhotic primary biliary cirrhosis.

Authors:  Malgorzata Milkiewicz; Justyna Kopycińska; Agnieszka Kempińska-Podhorodecka; Tara Haas; Dimitrios P Bogdanos; Elwyn Elias; Piotr Milkiewicz
Journal:  J Immunol Res       Date:  2014-02-05       Impact factor: 4.818

Review 10.  Immune heterogeneity in neuroinflammation: dendritic cells in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.